drugset / Trial / NCT05820685
Dronabinol On the Pain Experience
Phase 4
Terminated
484 enrolled
The University of Texas Health Science Center, Houston
The Eastern Association for the Surgery of Trauma · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to identify the effect dronabinol has on opioid exposure when used as an adjunct to the current standard multi-modal pain regimen (MMPR)
Timeline
- Start
- 2023-07-27
- Primary completion
- 2024-04-29
- Completion
- 2024-04-29
Outcome
Outcome not reported
Stopped: “Study concluded because of drug shortage”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dronabinol | Other / unclassified | 10 mg | — |
| Background | Acetaminophen | Small molecule | 1000 mg | — |
| Background | Gabapentin | Unknown | 300 mg | — |
| Background | Naproxen | Small molecule | 500 mg | — |
| Background | Oxycodone | Other / unclassified | 5 mg | — |
| Background | Tramadol | Other / unclassified | 50 mg | — |